Israel Englander Mersana Therapeutics, Inc. Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 1,507,580 shares of MRSN stock, worth $2.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,507,580

Previous 3,394,440 55.59%

Holding current value

$2.76 Million

Previous $7.88 Million 14.25%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$2.16 - $5.94 $4.08 Million - $11.2 Million	-1,886,860 Reduced 55.59%	1,507,580 $6.75 Million
Q4 2023 Feb 14, 2024	BUY	$1.11 - $2.34 $1.69 Million - $3.56 Million	1,522,523 Added 81.33%	3,394,440 $7.88 Million
Q2 2023 Aug 14, 2023	BUY	$3.08 - $9.55 $1.88 Million - $5.83 Million	610,863 Added 48.44%	1,871,917 $6.16 Million
Q1 2023 May 15, 2023	SELL	$4.0 - $7.02 $9.61 Million - $16.9 Million	-2,402,473 Reduced 65.58%	1,261,054 $5.18 Million
Q4 2022 Feb 14, 2023	SELL	$5.65 - $7.86 $681,661 - $948,293	-120,648 Reduced 3.19%	3,663,527 $21.5 Million

Q3 2022 Nov 14, 2022	SELL	$4.63 - $8.0 $2.77 Million - $4.79 Million	-598,526 Reduced 13.66%	3,784,175 $25.6 Million
Q2 2022 Aug 15, 2022	SELL	$2.84 - $5.0 $1.42 Million - $2.51 Million	-501,048 Reduced 10.26%	4,382,701 $20.2 Million
Q1 2022 May 16, 2022	BUY	$3.74 - $6.63 $15.9 Million - $28.2 Million	4,247,665 Added 667.78%	4,883,749 $19.5 Million
Q4 2021 Feb 14, 2022	BUY	$5.48 - $9.86 $2.92 Million - $5.25 Million	532,347 Added 513.17%	636,084 $3.96 Million
Q3 2021 Nov 15, 2021	SELL	$8.56 - $14.47 $1.9 Million - $3.22 Million	-222,406 Reduced 68.19%	103,737 $978,000
Q2 2021 Aug 16, 2021	BUY	$13.28 - $18.07 $510,908 - $695,189	38,472 Added 13.37%	326,143 $4.43 Million
Q1 2021 May 17, 2021	BUY	$15.31 - $26.52 $2.87 Million - $4.97 Million	187,468 Added 187.09%	287,671 $4.66 Million
Q3 2020 Nov 16, 2020	SELL	$16.2 - $25.7 $11 Million - $17.4 Million	-676,735 Reduced 87.1%	100,203 $1.87 Million
Q2 2020 Aug 14, 2020	BUY	$5.24 - $23.4 $1.38 Million - $6.17 Million	263,639 Added 51.36%	776,938 $18.2 Million
Q1 2020 May 14, 2020	SELL	$4.41 - $9.28 $1.28 Million - $2.69 Million	-290,242 Reduced 36.12%	513,299 $2.99 Million
Q4 2019 Feb 14, 2020	BUY	$1.45 - $6.73 $1.1 Million - $5.12 Million	761,017 Added 1789.62%	803,541 $4.6 Million
Q3 2019 Nov 14, 2019	SELL	$1.54 - $4.2 $42,285 - $115,323	-27,458 Reduced 39.24%	42,524 $67,000
Q2 2019 Aug 15, 2019	SELL	$3.84 - $6.4 $98,810 - $164,684	-25,732 Reduced 26.88%	69,982 $283,000
Q1 2019 May 14, 2019	BUY	$3.51 - $7.3 $180,617 - $375,643	51,458 Added 116.27%	95,714 $503,000
Q4 2018 Feb 14, 2019	SELL	$3.45 - $9.72 $1.12 Million - $3.16 Million	-325,467 Reduced 88.03%	44,256 $181,000
Q3 2018 Nov 14, 2018	BUY	$10.0 - $19.02 $2.47 Million - $4.69 Million	246,670 Added 200.46%	369,723 $3.7 Million
Q2 2018 Aug 14, 2018	BUY	$14.2 - $22.68 $1.75 Million - $2.79 Million	123,053 New	123,053 $2.2 Million
Q4 2017 Feb 14, 2018	SELL	$14.95 - $19.9 $826,077 - $1.1 Million	-55,256 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$14.8 - $18.06 $817,788 - $997,923	55,256	55,256 $955,000

Others Institutions Holding MRSN

# of Institutions

128

Shares Held

118M

Call Options Held

68.1K

Put Options Held

140K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $178M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account